June 07, 2017
Accepted abstract by ICML with updated results from Phase 1/2 trial of Betalutin® in NHL is now available on-line
Media
June 07, 2017
Positive results from the CER-209 Phase I Single Dose Tolerance study for NAFLD and NASH
June 06, 2017
Targovax presents further positive clinical data from TG01 phase I/II trial at 2017 ASCO annual meeting
June 02, 2017
Nordic Nanovector to Present at Jefferies Healthcare Conference in New York on Thursday June 8th
June 02, 2017
Orexo receives USD 2.5 million milestone payment from AstraZeneca as OX-CLI advances into clinical trials
May 24, 2017
Nordic Nanovector ASA – Results for First Quarter 2017
May 23, 2017
Onxeo Announces 10th Positive DSMB Recommendation to Continue Livatag® ReLive Phase III Trial in HCC
May 23, 2017
Aprea Therapeutics Announces First Patients Enrolled in Phase Ib/II Clinical Study of APR-246 for the Treatment of Myelodysplastic Syndrome
May 23, 2017
New Data from Two Multi-Center Randomized Clinical Trials Demonstrate That Zephyr Endobronchial Valves Deliver Benefit to Both Heterogeneous and Homogenous Emphysema Patients without Collateral Ventilation
May 22, 2017
Wilson Therapeutics Strengthens its Board of Directors by the Appointments of Birgitte Volck and Björn Odlander
